SWK Holdings provides portfolio update
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 06 2025
0mins
Recent Financial Advances: SWK provided various financial advances in November and December, including $5.0M to Journey Medical for Emrosi's launch, $8.0M to Triple Ring Technologies, and a $25.7M expansion of credit for Eton, among others.
Repayments Received: SWK received significant repayments totaling over $40M from various sources, including Biolase's bankruptcy estate and sales of assets, with additional payments anticipated in 2025.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
